Medicare Enrolled
Dr. Rajni Sinha, M.D.
Hematology & Oncology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sinha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sinha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sinha
Dr. Rajni Sinha is a hematology & oncology specialist in Atlanta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sinha performed 10,543 Medicare services across 1,363 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sinha received a total of $32,154 from 78 pharmaceutical and/or device companies across 502 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sinha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in GA
$32,154 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,543
Medicare services
Top 17% in GA for hematology & oncology
1,363
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~555 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,080 | $18 | $44 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,384 | $0 | $0 |
| Iron infusion (Monoferric) | 1,100 | $16 | $65 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
805 | $8 | $27 |
| Anti-nausea injection (Aloxi/palonosetron) | 630 | $1 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
468 | $93 | $260 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
399 | $61 | $168 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
265 | $101 | $525 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
252 | $22 | $118 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
195 | $11 | $60 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
157 | $12 | $82 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
114 | $49 | $250 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
82 | $26 | $126 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
81 | $1 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $123 | $429 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
62 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
52 | $22 | $131 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
49 | $42 | $218 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
40 | $10 | $97 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
39 | $48 | $235 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
35 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 33 | $166 | $544 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 31 | $337 | $1,325 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
27 | $2 | $5 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
25 | $3 | $15 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $25 | $194 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
20 | $60 | $172 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
15 | $31 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
12 | $68 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.3% high complexity
64.3% medium
18.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$32,154
Total received (2018-2024)
Avg $4,593/year across 7 years
Top 12% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
502
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,697 (67.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,600 (26.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,856 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,573
2023
$2,639
2022
$5,344
2021
$7,852
2020
$5,463
2019
$2,610
2018
$2,672
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$2,218
AstraZeneca Pharmaceuticals LP
$1,380
PFIZER INC.
$274
ABBVIE INC.
$264
Novartis Pharmaceuticals Corporation
$168
Merck Sharp & Dohme LLC
$160
Takeda Pharmaceuticals U.S.A., Inc.
$98
Janssen Biotech, Inc.
$91
Exelixis Inc.
$82
SpringWorks Therapeutics, Inc.
$69
Gilead Sciences, Inc.
$61
Bayer Healthcare Pharmaceuticals Inc.
$58
JAZZ PHARMACEUTICALS INC.
$54
Eisai Inc.
$52
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
GENZYME CORPORATION
$46
Adaptive Biotechnologies Corporation
$43
Stemline Therapeutics Inc.
$42
GlaxoSmithKline, LLC.
$41
Genentech USA, Inc.
$40
SOBI, INC
$39
Verity Pharmaceuticals Inc.
$38
Legend Biotech USA Inc.
$28
TerSera Therapeutics LLC
$27
Rigel Pharmaceuticals, Inc.
$25
BeiGene USA, Inc.
$23
ARRAY BIOPHARMA INC
$20
ADC Therapeutics America, Inc.
$19
EMD Serono, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 69.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$9,194
Daiichi Sankyo Inc.
$6,698
Bayer HealthCare Pharmaceuticals Inc.
$1,864
Seagen Inc.
$1,840
Exelixis Inc.
$1,786
Celgene Corporation
$1,504
Janssen Biotech, Inc.
$1,449
PFIZER INC.
$667
Novartis Pharmaceuticals Corporation
$552
BeiGene, Ltd.
$450
Genentech USA, Inc.
$448
Amgen Inc.
$335
E.R. Squibb & Sons, L.L.C.
$293
Takeda Pharmaceuticals U.S.A., Inc.
$293
Merck Sharp & Dohme LLC
$286
ABBVIE INC.
$264
Eisai Inc.
$234
GENZYME CORPORATION
$232
Merck Sharp & Dohme Corporation
$213
EISAI INC.
$184
GlaxoSmithKline, LLC.
$182
Pharmacyclics LLC, An AbbVie Company
$179
Gilead Sciences, Inc.
$160
AbbVie Inc.
$146
Array BioPharma Inc.
$146
Incyte Corporation
$125
Janssen Pharmaceuticals, Inc
$119
Ethicon US, LLC
$115
FUJIFILM Healthcare Americas Corporation
$112
Regeneron Healthcare Solutions, Inc.
$105
ARRAY BIOPHARMA INC
$104
BeiGene USA, Inc.
$102
Pharmacyclics LLC, an AbbVie Company
$94
Rigel Pharmaceuticals, Inc.
$88
Adaptive Biotechnologies Corporation
$88
Epizyme, Inc.,
$84
Bayer Healthcare Pharmaceuticals Inc.
$79
Seattle Genetics, Inc.
$76
ADC Therapeutics America, Inc.
$74
EMD Serono, Inc.
$70
SpringWorks Therapeutics, Inc.
$69
Stemline Therapeutics Inc.
$66
Astellas Pharma US Inc
$63
Lilly USA, LLC
$61
JAZZ PHARMACEUTICALS INC.
$54
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
Ipsen Biopharmaceuticals, Inc
$42
PUMA BIOTECHNOLOGY, INC.
$40
Mirati Therapeutics, Inc.
$39
SOBI, INC
$39
Alexion Pharmaceuticals, Inc.
$38
Verity Pharmaceuticals Inc.
$38
Karyopharm Therapeutics Inc.
$37
CTI BioPharma Corp.
$33
AbbVie, Inc.
$32
Legend Biotech USA Inc.
$28
TerSera Therapeutics LLC
$27
Foundation Medicine, Inc.
$27
Kite Pharma, Inc.
$27
G1 Therapeutics, Inc.
$23
TESARO, Inc.
$22
Puma Biotechnology, Inc.
$20
Coherus Biosciences Inc.
$20
Clovis Oncology, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
PORTOLA PHARMACEUTICALS, LLC
$19
Deciphera Pharmaceuticals Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$18
Myovant Sciences Inc.
$16
Agios Pharmaceuticals, Inc.
$16
Acrotech Biopharma LLC
$15
PORTOLA PHARMACEUTICALS, INC.
$15
Epizyme, Inc.
$15
Octapharma USA, Inc.
$12
Heron Therapeutics, Inc.
$12
Dova Pharmaceuticals
$11
Secura Bio, Inc.
$10
Sirtex Medical Inc
$8
Top 3 companies account for 55.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · ANDEXXA · Alecensa · Avastin · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Farydak · GAZYVA · GILOTRIF · HARMONIC Product Family · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PANZYGA · PIQRAY · PROMACTA · PYRUKYND · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · UTASWAKO AFP-L3 · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · YONSA · ZEJULA · ZEPZELCA · ZYKADIA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
178
Per 100K population
16.7
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sinha is a mixed practice specialist, with above-average Medicare volume (top 17% in GA), with consulting-driven industry engagement in the top 12% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sinha experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sinha performed 4,080 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sinha receive payments from pharmaceutical companies?
Yes. Dr. Sinha received a total of $32,154 from 78 companies across 502 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sinha's costs compare to other hematology & oncology specialists in Atlanta?
Dr. Sinha's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sinha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Atlanta
Browse hematology & oncology specialists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology